Daniel Virnich Oncology Institute, Inc. (TOI) insider trading activity

Daniel Virnich is Chief Executive Officer of Oncology Institute, Inc.. Currently has a direct ownership of 1.8 Million shares of TOI, which is worth approximately $7.15 Million. The most recent transaction as insider was on Nov 17, 2025, when has been sold 6,464 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.8M

0.71% 3M change

152.81% 12M change

Total Value Held $7.15 Million

Daniel Virnich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	BUY Grant, award, or other acquisition	-	6,464 Added 0.36%	1,799,984 Common Stock
Nov 12 2025	BUY Grant, award, or other acquisition	-	6,211 Added 0.35%	1,793,520 Common Stock
May 21 2025	SELL Sale (or disposition) back to the issuer	$54,435 $2.67 p/Share	20,388 Reduced 1.13%	1,787,309 Common Stock
Mar 31 2025	BUY Grant, award, or other acquisition	-	1,083,334 Added 37.47%	1,807,697 Common Stock
Mar 26 2025	BUY Open market or private purchase	$23,545 $1.04 p/Share	22,640 Added 3.03%	724,363 Common Stock
Mar 19 2025	SELL Sale (or disposition) back to the issuer	$9,132 $0.89 p/Share	10,261 Reduced 1.44%	701,723 Common Stock
Nov 20 2024	SELL Sale (or disposition) back to the issuer	$1,361 $0.14 p/Share	9,727 Reduced 1.35%	711,984 Common Stock

Nov 12 2024	SELL Other acquisition or disposition	-	195,236 Reduced 21.29%	721,711 Common Stock
May 21 2024	SELL Sale (or disposition) back to the issuer	$6,703 $0.6 p/Share	11,173 Reduced 1.53%	718,430 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	198,517 Added 17.8%	916,947 Common Stock
Nov 21 2023	SELL Sale (or disposition) back to the issuer	$9,465 $2.19 p/Share	4,322 Reduced 0.59%	729,603 Common Stock
Nov 14 2023	SELL Sale (or disposition) back to the issuer	$10,957 $2.38 p/Share	4,604 Reduced 0.62%	733,925 Common Stock
Mar 17 2023	BUY Grant, award, or other acquisition	-	114,944 Added 13.47%	738,529 Common Stock
Dec 07 2022	BUY Exercise of conversion of derivative security	$301,000 $0.86 p/Share	350,000 Added 35.95%	623,585 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	-	40,101 Added 12.78%	273,585 Common Stock
Nov 15 2022	SELL Sale (or disposition) back to the issuer	$7,647 $2.03 p/Share	3,767 Reduced 1.59%	233,484 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	-	42,015 Added 15.04%	237,251 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	-	195,236 Added 50.0%	195,236 Common Stock

Daniel Virnich

Chief Executive Officer

Cerritos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Value

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI

Account